Literature DB >> 25401232

Differences in fluorodeoxyglucose positron emission tomography/computed tomography findings between elderly onset rheumatoid arthritis and polymyalgia rheumatica.

Hiroyuki Takahashi1, Hiroyuki Yamashita, Kazuo Kubota, Yoko Miyata, Momoko Okasaki, Miyako Morooka, Yuko Takahashi, Hiroshi Kaneko, Toshikazu Kano, Akio Mimori.   

Abstract

OBJECTIVES: To compare the fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) findings in patients with elderly-onset rheumatoid arthritis (EORA) with those in patients with polymyalgia rheumatica (PMR), two conditions with similar clinical presentations.
METHODS: We retrospectively analyzed the FDG-PET/CT findings in 10 patients with EORA and 27 patients with PMR admitted to our department between 2006 and 2012.
RESULTS: No significant difference was observed in the median patient ages at the time of FDG-PET/CT scans in the EORA and PMR groups (73.5 vs. 78.0 years, respectively). Significant differences in both FDG uptake scores and standardized uptake values were observed between the two groups in the ischial tuberosities, spinous processes, and wrists. No significant differences were detected in the shoulders and hips. However, specific uptake patterns were observed in each group: circular and linear uptake patterns were observed around the humeral head in the EORA group, whereas focal and non-linear uptake patterns were observed in the PMR group. Moreover, focal uptake in front of the hip joint, indicating iliopectineal bursitis, tended to be limited to the PMR group. High sensitivity (92.6%) and specificity (90%) were observed for PMR diagnoses when at least three of the following five items were satisfied: characteristic findings of shoulder and iliopectineal bursitis, FDG uptake in ischial tuberosities and spinal spinous processes, and lack of FDG uptake in the wrists.
CONCLUSION: The differences in the degree of uptake at each lesion and in uptake patterns at the shoulders and hips are potentially useful for obtaining a definitive diagnosis.

Entities:  

Keywords:  Bursitis; Elderly-onset rheumatoid arthritis; Fluorodeoxyglucose positron emission tomography/computed tomography; Polymyalgia rheumatica

Mesh:

Substances:

Year:  2014        PMID: 25401232     DOI: 10.3109/14397595.2014.978936

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  16 in total

1.  FDG-PET imaging to detect and characterize underlying causes of fever of unknown origin: an unavoidable path for the foreseeable future.

Authors:  Abdullah Al-Zaghal; William Y Raynor; Siavash Mehdizadeh Seraj; Thomas J Werner; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01       Impact factor: 9.236

Review 2.  18F-FDG PET/CT in polymyalgia rheumatica-a pictorial review.

Authors:  Zdenek Rehak; Andrea Sprlakova-Pukova; Tomas Kazda; Zdenek Fojtik; Lenka Vargova; Petr Nemec
Journal:  Br J Radiol       Date:  2017-06-16       Impact factor: 3.039

3.  [Positron emission tomography/computed tomography in rheumatology].

Authors:  T Derlin
Journal:  Z Rheumatol       Date:  2017-09       Impact factor: 1.372

Review 4.  Clinical Nononcologic Applications of PET/CT and PET/MRI in Musculoskeletal, Orthopedic, and Rheumatologic Imaging.

Authors:  Ali Gholamrezanezhad; Kyle Basques; Ali Batouli; George Matcuk; Abass Alavi; Hossein Jadvar
Journal:  AJR Am J Roentgenol       Date:  2018-06       Impact factor: 3.959

5.  Early onset polymyalgia rheumatica: two rare cases under age of 50.

Authors:  Jinyoung Park; Duk Hyun Sung
Journal:  Skeletal Radiol       Date:  2017-03-21       Impact factor: 2.199

Review 6.  Optimal use of the FDG-PET/CT in the diagnostic process of fever of unknown origin (FUO): a comprehensive review.

Authors:  Ryogo Minamimoto
Journal:  Jpn J Radiol       Date:  2022-07-04       Impact factor: 2.374

Review 7.  2-deoxy-2[18F]fluoro-D-glucose positron emission tomography-computed tomography in rheumatological diseases.

Authors:  Manil Subesinghe; Shaheel Bhuva; Nikita Arumalla; Andrew Cope; David D'Cruz; Sujith Subesinghe
Journal:  Rheumatology (Oxford)       Date:  2022-05-05       Impact factor: 7.046

Review 8.  Pathogenesis, Diagnosis and Management of Polymyalgia Rheumatica.

Authors:  Dario Camellino; Andrea Giusti; Giuseppe Girasole; Gerolamo Bianchi; Christian Dejaco
Journal:  Drugs Aging       Date:  2019-11       Impact factor: 3.923

9.  Whole-body MRI of patients with polymyalgia rheumatica identifies a distinct subset with complete patient-reported response to glucocorticoids.

Authors:  Sarah Louise Mackie; Colin Thomas Pease; Eiji Fukuba; Emma Harris; Paul Emery; Richard Hodgson; Jane Freeston; Dennis McGonagle
Journal:  Ann Rheum Dis       Date:  2015-09-16       Impact factor: 19.103

10.  Differentiation between Polymyalgia Rheumatica (PMR) and Elderly-Onset Rheumatoid Arthritis Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Is Enthesitis a New Pathological Lesion in PMR?

Authors:  Daisuke Wakura; Takuya Kotani; Tohru Takeuchi; Tsuyoshi Komori; Shuzo Yoshida; Shigeki Makino; Toshiaki Hanafusa
Journal:  PLoS One       Date:  2016-07-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.